These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23946126)

  • 1. Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients.
    Yoo J; Hamilton SJ; Angel D; Fung K; Franklin J; Parnes LS; Lewis D; Venkatesan V; Winquist E
    Laryngoscope; 2014 Mar; 124(3):E87-94. PubMed ID: 23946126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy.
    Riga MG; Chelis L; Kakolyris S; Papadopoulos S; Stathakidou S; Chamalidou E; Xenidis N; Amarantidis K; Dimopoulos P; Danielides V
    Am J Clin Oncol; 2013 Feb; 36(1):1-6. PubMed ID: 22134515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are intratympanic injections of N-acetylcysteine and methylprednisolone protective against Cisplatin-induced ototoxicity?
    Saliba I; El Fata F; Ouelette V; Robitaille Y
    J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):236-43. PubMed ID: 20470667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transtympanic Injections of N-acetylcysteine and Dexamethasone for Prevention of Cisplatin-Induced Ototoxicity: Double Blind Randomized Clinical Trial.
    Sarafraz Z; Ahmadi A; Daneshi A
    Int Tinnitus J; 2018 Jun; 22(1):40-45. PubMed ID: 29993216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
    Murphy D; Daniel SJ
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.
    Chou YF; Chen PR; Kuo IJ; Yu SH; Wen YH; Wu HP
    Laryngoscope; 2013 Sep; 123(9):2264-9. PubMed ID: 23804460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Lansdaal PE; Rasch CR; Tange RA; Balm AJ; Dreschler WA
    Audiol Neurootol; 2006; 11(5):318-30. PubMed ID: 16983183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.
    Van Wijk F; Staecker H; Keithley E; Lefebvre PP
    Audiol Neurootol; 2006; 11(6):357-65. PubMed ID: 16988499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity.
    Nader ME; Théorêt Y; Saliba I
    Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
    Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
    J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted amelioration of cisplatin-induced ototoxicity in guinea pigs.
    Mohan S; Smyth BJ; Namin A; Phillips G; Gratton MA
    Otolaryngol Head Neck Surg; 2014 Nov; 151(5):836-9. PubMed ID: 25078416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of sudden sensorineural hearing loss with transtympanic injection of steroids as single therapy: a randomized clinical study.
    Dispenza F; Amodio E; De Stefano A; Gallina S; Marchese D; Mathur N; Riggio F
    Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1273-8. PubMed ID: 21327728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity.
    Feghali JG; Liu W; Van De Water TR
    Laryngoscope; 2001 Jul; 111(7):1147-55. PubMed ID: 11568534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss: a prospective, randomized trial.
    Lim HJ; Kim YT; Choi SJ; Lee JB; Park HY; Park K; Choung YH
    Otolaryngol Head Neck Surg; 2013 Jan; 148(1):121-7. PubMed ID: 23077155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can acetylcysteine ameliorate cisplatin-induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double-blind, placebo-controlled trial involving patients with head and neck cancer.
    Visacri MB; Quintanilha JCF; de Sousa VM; Amaral LS; de F L Ambrósio R; Calonga L; Curi SFBB; de T Leme MF; Chone CT; Altemani JMC; Mazzola PG; Malaguti C; Vercesi AE; Lima CSP; Moriel P
    Cancer Med; 2019 May; 8(5):2020-2030. PubMed ID: 30977273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of noise conditioning on cisplatin-induced ototoxicity: a pilot study.
    Theneshkumar S; Lorito G; Giordano P; Petruccelli J; Martini A; Hatzopoulos S
    Med Sci Monit; 2009 Jul; 15(7):BR173-7. PubMed ID: 19564816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
    Rolland V; Meyer F; Guitton MJ; Bussières R; Philippon D; Bairati I; Leclerc M; Côté M
    J Otolaryngol Head Neck Surg; 2019 Jan; 48(1):4. PubMed ID: 30651130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden sensorineural hearing loss: results of intratympanic steroids as salvage treatment.
    Dispenza F; De Stefano A; Costantino C; Marchese D; Riggio F
    Am J Otolaryngol; 2013; 34(4):296-300. PubMed ID: 23357592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.